{"id":69029,"date":"2026-03-13T12:12:34","date_gmt":"2026-03-13T12:12:34","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=69029"},"modified":"2026-10-15T10:33:59","modified_gmt":"2026-10-15T10:33:59","slug":"ss-31-elamipretide","status":"publish","type":"product","link":"https:\/\/medsbase.com\/it\/product\/ss-31-elamipretide\/","title":{"rendered":"SS-31 (Elamipretide)"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Risposta rapida \u2014 Cos'\u00e8 SS-31 (Elamipretide)?<\/h3>\n<p style=\"margin: 0;\"><strong>SS-31<\/strong> (chiamato anche <strong>Elamipretide<\/strong> o <strong>Bendavia<\/strong>) \u00e8 un tetrapeptide sintetico che si lega selettivamente <strong>cardiolipina<\/strong> on the inner mitochondrial membrane, stabilizing mitochondrial function under stress. Developed by the Szeto-Schiller lab and now in late-stage clinical development by Stealth BioTherapeutics with FDA orphan-drug designation for rare mitochondrial disease. Supplied in 5\u00a0mg to 50\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Cosa ottieni con MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/it\/reviews\/\">recensioni dei clienti<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Ogni ordine \u00e8 coperto dalla nostra <a href=\"https:\/\/medsbase.com\/it\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica di Garanzia di Rispedizione<\/strong><\/a> \u2014 se il tuo pacco non arriva entro 20 giorni lavorativi, lo rispediamo.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Specifiche<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Dettaglio<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Numero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">736992-21-5<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Formula Molecolare<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>32<\/sub>H<sub>49<\/sub>N<sub>9<\/sub>O<sub>5<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso molecolare<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">639.80 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequenza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">D-Arg-2\u2032,6\u2032-Dmt-Lys-Phe-NH<sub>2<\/sub> (Bendavia, MTP-131)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Polvere liofilizzata (o come fornito)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Purezza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificato con HPLC, COA disponibile su richiesta)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Conservazione<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizzato: 2\u20138 \u00b0C (frigorifero) per lo stock di lavoro; \u221220 \u00b0C per lo stoccaggio a lungo termine di flaconcini non aperti. Ricostituito: 2\u20138 \u00b0C, utilizzare entro ~30 giorni. Proteggere dalla luce. Non congelare e scongelare la soluzione ricostituita.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilit\u00e0<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Acqua batteriostatica (consigliata) o acqua sterile per finestre d'uso pi\u00f9 brevi<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Cos'\u00e8 SS-31 (Elamipretide)?<\/h2>\n<p><strong>SS-31<\/strong> \u00e8 un tetrapeptide sintetico permeabile alle cellule (D-Arg-2\u20196\u2032-dimetil-L-Tir-L-Lis-L-Phe, anche abbreviato <strong>Szeto-Schiller 31<\/strong>) sviluppato da Hazel Szeto e Peter Schiller al Weill Medical College della Cornell a partire dagli anni '90. \u00c8 anche noto con i suoi nomi di sviluppo farmaceutico <strong>Elamipretide<\/strong> e <strong>Bendavia<\/strong>, ed \u00e8 attualmente in fase di sviluppo clinico da <strong>Stealth BioTherapeutics<\/strong>. Unlike most peptides that bind cell-surface receptors, SS-31 is a <strong>agente mirato ai mitocondri<\/strong> che attraversa le membrane cellulari e degli organelli per raggiungere la membrana mitocondriale interna, dove si lega <strong>cardiolipina<\/strong> \u2014 a phospholipid unique to that location. This selective lipid binding underpins its mechanism of action and distinguishes SS-31 from virtually every other peptide. Molecular weight approximately 640\u00a0Da. SS-31 has <strong>la designazione di farmaco orfano da parte della FDA<\/strong> for primary mitochondrial myopathy and has been the subject of multiple human clinical trials \u2014 placing it further along the clinical development pipeline than most peptides. It is supplied here as a high-purity lyophilized powder <strong>for clinical studies use only<\/strong> (Stealth&#8217;s clinical product is a separate regulated therapeutic). For deeper mechanism, Szeto lab studies history, and clinical-trial context, see our <a href=\"https:\/\/medsbase.com\/it\/ss-31-elamipretide-mitochondrial-guide\/\">SS-31 guide<\/a>. <\/p>\n<h2>Meccanismo d'azione \u2014 Stabilizzazione mitocondriale mirata alla cardiolipina<\/h2>\n<p>SS-31&#8217;s mechanism is unique among peptides because its target is a phospholipid, not a receptor protein. Three interconnected effects define its pharmacology:<\/p>\n<ul>\n<li><strong>Legame alla cardiolipina<\/strong> \u2014 SS-31 si lega selettivamente alla cardiolipina sulla membrana mitocondriale interna. La cardiolipina \u00e8 un lipide caratteristico che si trova quasi esclusivamente in questa sede ed \u00e8 essenziale per l'architettura delle creste (la superficie ripiegata della membrana interna dove si raggruppano i complessi della catena di trasporto degli elettroni). Il legame di SS-31 <strong>stabilizza la morfologia delle creste<\/strong> durante stress che altrimenti causerebbe la disgregazione delle creste e disfunzione mitocondriale.<\/li>\n<li><strong>Riduzione delle ROS e preservazione della catena di trasporto degli elettroni<\/strong> \u2014 by preserving cristae architecture, SS-31 maintains the proper organization of electron-transport-chain complexes, preserving ATP synthesis and reducing electron &#8220;leakage&#8221; that generates reactive oxygen species. In ischemia-reperfusion study models, this translates to reduced oxidative damage and preserved mitochondrial function.<\/li>\n<li><strong>Prevenzione del rilascio del citocromo c<\/strong> \u2014 mitochondrial apoptosis begins with cytochrome c release from the inner membrane space into the cytoplasm. By preserving cristae structure, SS-31 preserves cytochrome c localization and blocks a critical apoptotic trigger. This is central to its cardiac ischemia-reperfusion signal.<\/li>\n<\/ul>\n<p>The practical studies implication: SS-31 is the reference mitochondria-targeted peptide. Where other peptides act at cell-surface receptors, SS-31 acts inside the organelle, preserving mitochondrial function in study models of metabolic stress, ischemia, and aging. <\/p>\n<h2>Published Evidence<\/h2>\n<p>SS-31 is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Primary mitochondrial disease studies<\/strong> \u2014 rare mitochondrial myopathy studies including Barth syndrome; SS-31 has FDA orphan-drug designation for this indication<\/li>\n<li><strong>Cardiac studies<\/strong> \u2014 heart failure, ischemia-reperfusion, cardiomyopathy, and cardiotoxicity rescue studies (Szeto, AAPS J 2014)<\/li>\n<li><strong>Renal studies<\/strong> \u2014 acute kidney injury, ischemia-reperfusion, and chronic kidney disease studies (Birk et al., J Am Soc Nephrol 2013)<\/li>\n<li><strong>Aging studies<\/strong> \u2014 disfunzione mitocondriale legata all'et\u00e0, invecchiamento del muscolo scheletrico (sarcopenia) e marcatori generali dell'invecchiamento cellulare<\/li>\n<li><strong>Neuroprotection studies<\/strong> \u2014 ischemic-stroke and neurodegeneration studies where mitochondrial dysfunction is a driver<\/li>\n<li><strong>Sarcopenia studies<\/strong> \u2014 skeletal-muscle mitochondrial function and age-related muscle loss studies<\/li>\n<li><strong>Comparative mitochondrial-agent studies<\/strong> \u2014 a confronto con <a href=\"https:\/\/medsbase.com\/it\/nad\/\">NAD+<\/a> (coenzima mitocondriale) e MitoQ (un altro antiossidante mirato ai mitocondri) per isolare il meccanismo<\/li>\n<\/ul>\n<p>For broader context on longevity and mitochondrial-compounds see the <a href=\"https:\/\/medsbase.com\/it\/peptides\/\">catalogo peptidi<\/a>. <\/p>\n<h2>Concentrazioni e Dosaggi Disponibili<\/h2>\n<p>MedsBase dispone di SS-31 (Elamipretide) nelle seguenti dimensioni di fiale liofilizzate:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Dosaggio per Flaconcino<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso d'Uso Tipico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Dimensioni della Confezione<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Short protocols, low-dose rodent work<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 fiale<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength, extended rodent studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 fiale<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>50 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Large-scale studies, clinical-trial-matched doses (40 mg\/day), lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 fiale<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The 50\u00a0mg vial size matches the clinical-trial 40 mg\/day dose used in Stealth BioTherapeutics&#8217;s human studies. Preclinical rodent studies typically uses smaller vials matched to 1\u20135 mg\/kg body weight. All strengths are supplied as lyophilized powder at 99%+ HPLC purity. <\/p>\n<h2>Confronto \u2014 SS-31 vs Altri Composti Mitocondriali \/ Longevit\u00e0<\/h2>\n<p>SS-31 is part of a small but growing class of mitochondria-targeted studies agents. Key comparisons:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Criterio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">SS-31 (Elamipretide)<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">NAD+<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Epitalon<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Bersaglio primario<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Cardiolipina (lipide della membrana mitocondriale interna)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Sirtuine, enzimi PARP, ETC<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Espressione genica, segnalazione pineale<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Evidenza meccanicistica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Forte (multipli laboratori, studi clinici)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Molto forte (biochimica ben caratterizzata)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Gruppo ristretto (Khavinson)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Stato clinico<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Farmaco orfano FDA, Fase 3 (sindrome di Barth)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Non approvato (uso in terapia endovenosa)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Non approvato<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Strongest signal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ischemia cardiaca, renale, sarcopenia<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Longevit\u00e0, energia, riparazione del DNA<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Telomeri, ritmo circadiano<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Dosaggio tipico<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">5\u201340 mg al giorno (clinico); 1\u20135 mg\/kg (preclinico)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">50\u2013100 mg al giorno<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">5\u201310 mg SC al giorno<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>SS-31 is distinct because it is the only peptide targeting a mitochondrial lipid directly. Users often study it alongside <a href=\"https:\/\/medsbase.com\/it\/nad\/\">NAD+<\/a> (per una copertura complementare della via delle sirtuine) e <a href=\"https:\/\/medsbase.com\/it\/epitalon\/\">Epitalon<\/a> in multi-pathway longevity protocols. <\/p>\n<h2>Conservazione e ricostituzione<\/h2>\n<p><strong>Prima della ricostituzione:<\/strong> conservare i flaconcini liofilizzati refrigerati a 2\u20138 \u00b0C nella confezione originale, stabili fino a 36 mesi. Evitare cicli di congelamento-scongelamento della polvere. <strong>Procedura di ricostituzione:<\/strong> iniettare acqua batteriostatica lungo la parete laterale del flaconcino di peptidi come indicato nella tabella sopra. Agitare delicatamente \u2014 non <strong>not<\/strong> scuotere \u2014 e lasciare riposare per 5\u201310 minuti per una completa dissoluzione. La soluzione dovrebbe essere chiara e incolore. <strong>Dopo la ricostituzione:<\/strong> conservare in frigorifero a 2\u20138\u00a0\u00b0C e utilizzare entro 30 giorni. Non congelare la soluzione ricostituita. <\/p>\n<h2 id=\"faqs\">Domande frequenti<\/h2>\n<h3>What is SS-31 used for in studies?<\/h3>\n<p>SS-31 (Elamipretide) is used in studies investigating mitochondrial disease (including Barth syndrome), cardiac ischemia-reperfusion, heart failure, acute kidney injury, chronic kidney disease, age-related mitochondrial dysfunction, sarcopenia, and neuroprotection. It has FDA orphan-drug designation but is <strong>not<\/strong> yet FDA-approved for therapeutic use. Sold here strictly for clinical studies use only. <\/p>\n<h3>How is SS-31 different from other peptides?<\/h3>\n<p>SS-31 \u00e8 unico perch\u00e9 il suo bersaglio \u00e8 <strong>cardiolipina<\/strong> \u2014 a phospholipid on the inner mitochondrial membrane \u2014 not a cell-surface receptor. It is cell-permeable and reaches the mitochondrial matrix to stabilize cristae architecture and preserve electron-transport-chain function. Virtually every other peptide binds receptors on the cell surface. <\/p>\n<h3>What is the typical SS-31 dose?<\/h3>\n<p>Stealth BioTherapeutics&#8217; clinical trials have used 40\u00a0mg SC daily. Preclinical rodent studies typically uses 1\u20135\u00a0mg\/kg body weight daily. A 10\u00a0mg vial reconstituted with 2.0\u00a0mL bacteriostatic water yields 5.0\u00a0mg\/mL \u2014 100 ticks on a U-100 syringe delivers 5\u00a0mg. <\/p>\n<h3>SS-31 \u00e8 approvato dalla FDA?<\/h3>\n<p>SS-31 (Elamipretide) ha la designazione di farmaco orfano della FDA per la miopatia mitocondriale primaria ed \u00e8 in fase avanzata di sviluppo clinico da parte di Stealth BioTherapeutics. Non \u00e8 <strong>not<\/strong> yet fully FDA-approved. All SS-31 sold by specialist suppliers is for clinical investigation, not the clinical-trial therapeutic product. <\/p>\n<h3>Cosa significa l'abbreviazione \u201cSS-31\u201d?<\/h3>\n<p>SS-31 sta per <strong>composto Szeto-Schiller 31<\/strong>, after the Cornell users Hazel Szeto and Peter Schiller who developed the SS-series of mitochondria-targeted peptides in the 1990s and 2000s. The &#8220;31&#8221; is simply the compound number in their synthesis series. The compound was later licensed to Stealth BioTherapeutics and renamed Elamipretide (and Bendavia) for clinical development. <\/p>\n<h3>Come va conservato SS-31?<\/h3>\n<p>Flaconcini liofilizzati: refrigerati a 2\u20138\u00a0\u00b0C nella confezione originale, stabili fino a 36 mesi. Soluzione ricostituita: refrigerata a 2\u20138\u00a0\u00b0C, utilizzare entro 30 giorni. Non congelare la soluzione ricostituita. <\/p>\n<h3>Come si ricostituisce SS-31?<\/h3>\n<p>Segui la tabella di ricostituzione sopra riportata. Aggiungi acqua batteriostatica lungo la parete laterale del flaconcino, agita delicatamente e attendi 5-10 minuti per la completa dissoluzione. Non <strong>not<\/strong> agitare. <\/p>\n<h3>Can SS-31 be stacked with NAD+ in studies?<\/h3>\n<p>Yes \u2014 this is a common multi-pathway mitochondrial studies combination. SS-31 stabilizes cristae architecture and cardiolipin-dependent ETC function; <a href=\"https:\/\/medsbase.com\/it\/nad\/\">NAD+<\/a> fornisce substrato coenzimatico per la catena di trasporto degli elettroni e la segnalazione a valle delle sirtuine\/PARP. I meccanismi sono complementari e non sovrapposti. <\/p>\n<h3>Quali dosaggi sono disponibili su MedsBase?<\/h3>\n<p>MedsBase carries SS-31 (Elamipretide) in 5\u00a0mg, 10\u00a0mg, and 50\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis on request. <\/p>\n<h3>Does SS-31 cause side reported effects?<\/h3>\n<p>Published preclinical and clinical-trial has reported a favorable safety profile. Most commonly reported effects in the clinical-trial literature are injection-site reactions. Because SS-31 has been studied in multiple human trials (Phase 2 and Phase 3), its safety profile is better-characterised than most peptides. <\/p>\n<h3>SS-31 \u00e8 lo stesso di Bendavia o Elamipretide?<\/h3>\n<p>S\u00ec. Lo stesso composto ha tre nomi: <strong>SS-31<\/strong> (original Szeto-Schiller studies designation), <strong>Bendavia<\/strong> (nome dello sviluppo iniziale di Stealth BioTherapeutics), e <strong>Elamipretide<\/strong> (international nonproprietary name \/ INN). Studies literature uses SS-31 predominantly; clinical-trial literature uses Elamipretide or Bendavia. <\/p>\n<h3>Qual \u00e8 l'emivita di SS-31?<\/h3>\n<p>SS-31 (elamipretide) ha una breve emivita plasmatica di circa 30-60 minuti dopo somministrazione sottocutanea, ma dimostra un accumulo mitocondriale prolungato grazie alla sua affinit\u00e0 per la cardiolipina nella membrana mitocondriale interna. L'emivita tissutale in organi ricchi di mitocondri come il muscolo cardiaco e scheletrico \u00e8 stimata in diverse ore oltre la clearance plasmatica. <\/p>\n<h3>Come fa SS-31 a bersagliare specificamente i mitocondri?<\/h3>\n<p>SS-31 \u00e8 un peptide Szeto-Schiller con una struttura aromatica-cationica alternata (D-Arg-dimetil-Tyr-Lys-Phe-NH\u2082). Questa sequenza determina un accumulo nella membrana mitocondriale interna circa 1.000 volte superiore ai livelli citoplasmatici, mediato dall'attrazione elettrostatica verso il fosfolipide cardiolipina caricato negativamente. Il legame con la cardiolipina stabilizza i complessi della catena di trasporto degli elettroni e riduce la produzione di specie reattive dell'ossigeno (ROS). <\/p>\n<h3>Posso ordinare SS-31 per la spedizione internazionale?<\/h3>\n<p>S\u00ec. MedsBase spedisce SS-31 in tutto il mondo dalla nostra rete dedicata di spedizione di peptidi. Gli ordini contenenti solo peptidi si qualificano per il nostro servizio di spedizione dedicato. Gli ordini vengono spediti in imballaggi a temperatura controllata con tracciamento completo. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Recovery and Performance<\/h2>\n<ul>\n<li><a href=\"\/it\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tendon, ligament, gut recovery<\/li>\n<li><a href=\"\/it\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Thymosin Beta-4 fragment \u2014 soft tissue and vascular recovery<\/li>\n<li><a href=\"\/it\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 Agonista selettivo della grelina \u2014 pulso pulito di GH senza cortisolo\/prolattina<\/li>\n<li><a href=\"\/it\/cjc-1295-with-dac\/\"><strong>CJC-1295 con DAC<\/strong><\/a> \u2014 Analogico GHRH con emivita prolungata<\/li>\n<li><a href=\"\/it\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Copper peptide \u2014 skin and connective tissue regeneration<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Approfondimenti<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Learn the science behind this peptide<\/strong><\/p>\n<p style=\"margin: 0;\">Leggi la nostra guida completa basata sull'evidenza: <a href=\"https:\/\/medsbase.com\/it\/ss-31-elamipretide-mitochondrial-guide\/\"><strong>SS-31 (Elamipretide) \u2014 cardiolipin targeting, mitochondrial studies &amp; clinical trials<\/strong><\/a>. Covers Szeto-Schiller mechanism studies, Stealth BioTherapeutics clinical development, cardiac\/renal\/neurological applications, and realistic context.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Migliora l'energia cellulare<br \/>\n\u2705 Supporta la funzione mitocondriale<br \/>\n\u2705 Riduce lo stress ossidativo<br \/>\n\u2705 Migliora la resilienza dei tessuti<br \/>\n\u2705 Promuove l'efficienza metabolica<\/p>\n<p><strong>SS-31<\/strong> contiene composto peptidico sintetico.<\/p>","protected":false},"featured_media":70982,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5476,5475],"class_list":["post-69029","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-elamipretide","product_tag-ss-31","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product\/69029","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/comments?post=69029"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/media\/70982"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/media?parent=69029"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product_brand?post=69029"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product_cat?post=69029"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product_tag?post=69029"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}